OncologySeattleOffice$3.375BillionExitCPRITAdvisory&CorporateBoardsCSABMembers?UniformedServicesUniversity2014 Top-quartileRankedSanDiegoOfficeNewYorkOfficeSubstantialExitHistory$1 BillionGenentechCollaborationDiversityTachiYamada,M.D.PfizerVenturesOperatingPartners?BruceL.A.Carter,Ph.D.AlexandriaVentureInvestmentsTop-tierInvestorsReviewed >4,000OpportunitiesApogenBiotechnologiesGatesFoundationSteveGillis,Ph.D.AI &MachineLearningWeillCornellMedicine1.02DPIScientists&TechnologyDevelopersMDAndersonCancerCenterTurn-KeyFacilitiesDivestitures150+Years’Experience2.85DVPIMagnoliaNeurosciencesEntrepreneursCapital-efficiencyCaseWesternReserveExceptionalTrackRecordNon-DilutiveFundingPronirasWRFCapitalSyndicationPartnersAcademic&ResearchInstitutionsColumbiaUniversityDanaFarberCancer$12.3MillionNIDAGrantEliLillyPetraPharmaSingaporeOfficeJanLundberg,Ph.D.GeneYeo,Ph.D.TargetedTherapeutic(Asset)FinancingAbbvieStrategicPartnershipsNeuroscience& NeurologyLeroyHood,M.D.,Ph.D.WuXiPharmaTechEmployeesLydianNeurosciencesHarvardMedicalSchool(BARDA)– onupdatedslide deckSundarKodiyalamRodeoTherapeuticsTemasekLodoTherapeuticsPennStateUniversityofMinnesotaCorporateSpinoutsTheRockefellerUniversityUTSouthwesternMedicalCenterScientificExpertise58.43%IRRARCHVenturePartnersOncologySeattleOffice$3.375BillionExitCPRITAdvisory&CorporateBoardsCSABMembers?UniformedServicesUniversity2014 Top-quartileRankedSanDiegoOfficeNewYorkOfficeSubstantialExitHistory$1 BillionGenentechCollaborationDiversityTachiYamada,M.D.PfizerVenturesOperatingPartners?BruceL.A.Carter,Ph.D.AlexandriaVentureInvestmentsTop-tierInvestorsReviewed >4,000OpportunitiesApogenBiotechnologiesGatesFoundationSteveGillis,Ph.D.AI &MachineLearningWeillCornellMedicine1.02DPIScientists&TechnologyDevelopersMDAndersonCancerCenterTurn-KeyFacilitiesDivestitures150+Years’Experience2.85DVPIMagnoliaNeurosciencesEntrepreneursCapital-efficiencyCaseWesternReserveExceptionalTrackRecordNon-DilutiveFundingPronirasWRFCapitalSyndicationPartnersAcademic&ResearchInstitutionsColumbiaUniversityDanaFarberCancer$12.3MillionNIDAGrantEliLillyPetraPharmaSingaporeOfficeJanLundberg,Ph.D.GeneYeo,Ph.D.TargetedTherapeutic(Asset)FinancingAbbvieStrategicPartnershipsNeuroscience& NeurologyLeroyHood,M.D.,Ph.D.WuXiPharmaTechEmployeesLydianNeurosciencesHarvardMedicalSchool(BARDA)– onupdatedslide deckSundarKodiyalamRodeoTherapeuticsTemasekLodoTherapeuticsPennStateUniversityofMinnesotaCorporateSpinoutsTheRockefellerUniversityUTSouthwesternMedicalCenterScientificExpertise58.43%IRRARCHVenturePartners

Untitled Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
I
2
O
3
G
4
N
5
I
6
B
7
G
8
O
9
B
10
G
11
I
12
O
13
N
14
O
15
I
16
I
17
N
18
B
19
B
20
B
21
G
22
B
23
G
24
G
25
B
26
O
27
N
28
I
29
G
30
O
31
B
32
B
33
I
34
I
35
B
36
I
37
I
38
O
39
B
40
N
41
N
42
B
43
O
44
I
45
O
46
G
47
N
48
N
49
G
50
I
51
O
52
I
53
G
54
N
55
O
56
G
57
I
58
N
59
N
60
B
61
B
62
O
63
O
64
I
65
N
66
B
67
G
68
N
69
G
70
N
71
G
72
O
  1. I-Oncology
  2. O-Seattle Office
  3. G-$3.375 Billion Exit
  4. N-CPRIT
  5. I-Advisory & Corporate Boards
  6. B-CSAB Members?
  7. G-Uniformed Services University
  8. O-2014 Top-quartile Ranked
  9. B-San Diego Office
  10. G-New York Office
  11. I-Substantial Exit History
  12. O-$1 Billion Genentech Collaboration
  13. N-Diversity
  14. O-Tachi Yamada, M.D.
  15. I-Pfizer Ventures
  16. I-Operating Partners?
  17. N-Bruce L.A. Carter, Ph.D.
  18. B-Alexandria Venture Investments
  19. B-Top-tier Investors
  20. B-Reviewed > 4,000 Opportunities
  21. G-Apogen Biotechnologies
  22. B-Gates Foundation
  23. G-Steve Gillis, Ph.D.
  24. G-AI & Machine Learning
  25. B-Weill Cornell Medicine
  26. O-1.02 DPI
  27. N-Scientists & Technology Developers
  28. I-MD Anderson Cancer Center
  29. G-Turn-Key Facilities
  30. O-Divestitures
  31. B-150+ Years’ Experience
  32. B-2.85 DVPI
  33. I-Magnolia Neurosciences
  34. I-Entrepreneurs
  35. B-Capital-efficiency
  36. I-Case Western Reserve
  37. I-Exceptional Track Record
  38. O-Non-Dilutive Funding
  39. B-Proniras
  40. N-WRF Capital
  41. N-Syndication Partners
  42. B-Academic & Research Institutions
  43. O-Columbia University
  44. I-Dana Farber Cancer
  45. O-$12.3 Million NIDA Grant
  46. G-Eli Lilly
  47. N-Petra Pharma
  48. N-Singapore Office
  49. G-Jan Lundberg, Ph.D.
  50. I-Gene Yeo, Ph.D.
  51. O-Targeted Therapeutic (Asset) Financing
  52. I-Abbvie
  53. G-Strategic Partnerships
  54. N-Neuroscience & Neurology
  55. O-Leroy Hood, M.D., Ph.D.
  56. G-WuXi PharmaTech
  57. I-Employees
  58. N-Lydian Neurosciences
  59. N-Harvard Medical School
  60. B-(BARDA) – on updated slide deck
  61. B-Sundar Kodiyalam
  62. O-Rodeo Therapeutics
  63. O-Temasek
  64. I-Lodo Therapeutics
  65. N-Penn State
  66. B-University of Minnesota
  67. G-Corporate Spinouts
  68. N-The Rockefeller University
  69. G-UT Southwestern Medical Center
  70. N-Scientific Expertise
  71. G-58.43% IRR
  72. O-ARCH Venture Partners